“重磅炸弹”药品是一些非专利药厂商追逐的目标。本文中列出2013年专利保护期截止的约120个药品中销售额领先的前15个品种(表1)。国际医药资讯研究机构EvaluatePharma确认:按目前数据,总计达290亿美元年销售额的药品它们的(原始)专利会在2013年到期。今年因专利到期的药品销售额损失合计约670亿美元,虽然2013年总计损失少于2012年, “Blockbuster” drugs are the target pursued by some generic drug manufacturers. This article lists the top 15 products with sales leading to approximately 120 out of the 2013 patent expiration dates (Table 1). EvaluatePharma, an international medical information research firm, confirmed that based on the current data, a total of 29 billion U.S. dollars in annual sales of their drugs will expire in 2013. This year due to patent losses of pharmaceutical sales totaled about 67 billion US dollars, although the total loss in 2013 less than in 2012,